Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diacerein for Glycemic Control and Liver Fat in T2DM
NCT02242149Phase 3Completed
- Sponsor
- Federal University of Rio de Janeiro
- Start
- Oct 2014
- Primary completion
- Jan 2017
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of diacerein in type 2 diabetes mellitus (T2DM), non-alcoholic fatty liver disease (NAFLD), sponsored by Federal University of Rio de Janeiro. Started Oct 2014; status: completed.
02
Drugs
diacerein
03
Conditions
type 2 diabetes mellitus (T2DM)non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT02242149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02242149.